TORONTO, May 11, 2022
/CNW/ - DRI Healthcare Trust
(TSX: DHT.UN)
(TSX: DHT.U)
("DRI" or "the Trust") is pleased to announce
results of voting at its annual general meeting
("AGM") of unitholders held on
May 11, 2022. All of the nominees for
election as trustees of the Trust referred to in its management
information circular dated March 25,
2022 were elected to serve as trustees for the ensuing year,
and Deloitte LLP was reappointed as
auditors of the Trust.
Election of Trustees
Voting results for the election of each trustee were as
follows:
Trustee
|
Votes "for" as a
percentage
of votes cast for or withheld
for the trustee
|
|
Votes "withheld" as
a
percentage of votes cast for
or withheld for the trustee
|
Gary Collins
|
99.96%
|
|
0.04%
|
Ali Hedayat
|
94.59%
|
|
5.41%
|
Behzad
Khosrowshahi
|
99.99%
|
|
0.01%
|
Kevin Layden
|
94.59%
|
|
5.41%
|
Paul
Mussenden
|
80.11%
|
|
19.89%
|
Sandra
Stuart
|
85.77%
|
|
14.23%
|
Tamara
Vrooman
|
99.96%
|
|
0.04%
|
Appointment of Auditors
Unitholders also voted in favour of reappointing Deloitte LLP as
auditors of the Trust and authorizing the board of trustees to fix
their remuneration (99.998% in favour).
About DRI Healthcare
Trust
DRI Healthcare Trust provides unitholders with differentiated
exposure to the anticipated growth in the global pharmaceuticals
and biotechnology markets. Our business model is focused on
managing and growing a diversified portfolio of pharmaceutical
royalties with the aim to deliver attractive growth in cash royalty
receipts over the long term. DRI Healthcare Trust is an
unincorporated open-ended trust governed by the laws of the
Province of Ontario, externally
managed by its manager, DRI Capital Inc. DRI Healthcare Trust's
units are listed and trade on the Toronto Stock Exchange in
Canadian dollars under the symbol "DHT.UN" and in U.S. dollars
under the symbol "DHT.U".
SOURCE DRI Healthcare Trust